
Sherlock 3CG+ Launched in India; Designed to Improve Accuracy and Efficiency of PICC Line Placement in Cancer Patients
BD (Becton, Dickinson and Company) India announced the national launch of Sherlock 3CG+ recently through a 4-city roadshow in Delhi, Mumbai, Chennai and Kolkata. In current Indian clinical practice, typically for cancer patients and long term IV access, confirming PICC



